Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-12

FDA Approved: NUZOLVENCE — Original Application (La Jolla Pharmaceutical Company)

View source ↗

Summary

FDA approved NUZOLVENCE (zoliflodacin) under the original application by La Jolla Pharmaceutical Company for the treatment of gonorrhea. This marks the approval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUZOLVENCE (zoliflodacin)

Snippet

ORIG AP for NUZOLVENCE (ZOLIFLODACIN)